Up to Date Treatment of Hair Loss: Sublingual Minoxidil

Dr. Rodney Sinclair discussed sublingual minoxidil as a treatment for hair loss, highlighting its origins and research developments since 2015. He emphasized the advantages of low-dose oral minoxidil, with successful treatments conducted on over 100,000 patients without serious side effects. Key findings include the understanding of hair growth mechanisms, such as the relationship between hair follicle miniaturization and the duration of the anagen phase. Sinclair noted that sublingual minoxidil provides a safer alternative as it bypasses the liver, minimizing blood pressure effects while delivering the drug directly to hair follicles. The sublingual form has shown promise in enhancing hair growth and thickness with fewer side effects, particularly for women who worry about hypertrichosis. Treatment requires careful patient assessment, personalized dosing strategies, and long-term commitment. Data from studies indicate that doses around 4 milligrams tend to result in superior hair growth outcomes, including the reversal of miniaturization of hair fibers. Sinclair concluded that sublingual minoxidil could revolutionize androgenetic alopecia treatment and is well-received in clinical practice.